CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial
Autor: | Laterre, Pierre-François, Colin, Gwenhael, Dequin, Pierre-François, Dugernier, Thierry, Boulain, Thierry, Azeredo da Silveira, Samareh, Lajaunias, Frédéric, Perez, Antonio, François, Bruno |
---|---|
Zdroj: | In The Lancet Infectious Diseases June 2019 19(6):620-630 |
Databáze: | ScienceDirect |
Externí odkaz: |